Trust Company’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Trust Company’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-991	Closed	-$10K	–	349
2021 Q4	$10K	Hold	991	–	–	﹤0.01%	261
2021 Q3	$34K	Hold	991	–	–	0.01%	194
2021 Q2	$36K	Hold	991	–	–	0.03%	185
2021 Q1	$44K	Hold	991	–	–	0.03%	180
2020 Q4	$57K	Hold	991	–	–	0.05%	153
2020 Q3	$51K	Hold	991	–	–	0.04%	164
2020 Q2	$59K	Hold	991	–	–	0.06%	144
2020 Q1	$41K	Hold	991	–	–	0.05%	149
2019 Q4	$62K	Hold	991	–	–	0.05%	140
2019 Q3	$34K	Hold	991	–	–	0.03%	168
2019 Q2	$22K	Hold	991	–	–	0.02%	196
2019 Q1	$23K	Hold	991	–	–	0.01%	219
2018 Q4	$21K	Hold	991	–	–	0.01%	210
2018 Q3	$38K	Hold	991	–	–	0.02%	178
2018 Q2	$39K	Buy	+991	New	+$29.2K	0.02%	184

Other funds holding DCPH

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Trust Company's DCPH Position: Q1 2022 in Review

Trust Company sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2022, closing a stake of 991 shares — an estimated $10K sold.

Trust Company first reported a position in DCPH in Q2 2018 and held it in 15 quarters. The position peaked at $62K in Q4 2019. 123 funds tracked by Wall St. Rank hold DCPH as of Q1 2022.

Trust Company reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Trust Company sold 991 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $10K.
Trust Company first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 15 quarters.
Trust Company's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $62K in Q4 2019.
123 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Trust Company's 13F filing for Q1 2022, filed 8 Apr 2022.